Christer Sundström

MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

Rodrigues, Joana M.; Hollander, Peter; Schmidt, Lina; Gkika, Eirinaios et al.

Part of Haematologica, p. 1171-1183, 2024

• DOI for MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study
• Download full text (pdf) of MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma

Thurner, Lorenz; Fadle, Natalie; Regitz, Evi; Roth, Sophie et al.

Part of Haematologica, p. 3347-3358, 2023

• DOI for B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
• Download full text (pdf) of B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Stratmann, Svea; Vesterlund, Mattias; Umer, Husen M.; Skaftason, Aron et al.

Part of Leukemia, p. 550-559, 2023

• DOI for Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
• Download full text (pdf) of Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy

Leich, E.; Brodtkorb, Marianne; Schmidt, T.; Altenbuchinger, M. et al.

Part of Leukemia and Lymphoma, p. 1927-1937, 2023

• DOI for Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Abdulla, Maysaa; Sundström, Christer; Lindskog, Cecilia; Hollander, Peter

Part of Biomolecules, 2023

• DOI for Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
• Download full text (pdf) of Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

Rodrigues, Joana M.; Hollander, Peter; Schmidt, Lina; Gkika, Eirinaios et al.

Part of Haematologica, p. 1171-1183, 2024

• DOI for MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study
• Download full text (pdf) of MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma

Thurner, Lorenz; Fadle, Natalie; Regitz, Evi; Roth, Sophie et al.

Part of Haematologica, p. 3347-3358, 2023

• DOI for B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
• Download full text (pdf) of B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Stratmann, Svea; Vesterlund, Mattias; Umer, Husen M.; Skaftason, Aron et al.

Part of Leukemia, p. 550-559, 2023

• DOI for Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
• Download full text (pdf) of Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy

Leich, E.; Brodtkorb, Marianne; Schmidt, T.; Altenbuchinger, M. et al.

Part of Leukemia and Lymphoma, p. 1927-1937, 2023

• DOI for Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Abdulla, Maysaa; Sundström, Christer; Lindskog, Cecilia; Hollander, Peter

Part of Biomolecules, 2023

• DOI for Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
• Download full text (pdf) of Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Hellbacher, Erik; Sundström, Christer; Molin, Daniel; Baecklund, Eva et al.

Part of Cancers, 2022

• DOI for Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity
• Download full text (pdf) of Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Abdulla, Maysaa; Hollander, Peter; Lindskog, Cecilia; Sundström, Christer et al.

Part of Acta Oncologica, p. 824-829, 2022

• DOI for Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Loss of function mutations of BCOR in classical Hodgkin lymphoma

Giefing, Maciej; Gearhart, Micah D.; Schneider, Markus; Overbeck, Birte et al.

Part of Leukemia and Lymphoma, p. 1080-1090, 2022

• DOI for Loss of function mutations of BCOR in classical Hodgkin lymphoma

Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

Part of Blood Advances, p. 152-164, 2022

• DOI for Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression
• Download full text (pdf) of Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs: a Swedish cohort study of risks by time, drug and lymphoma subtype

Hellgren, Karin; Di Giuseppe, Daniela; Smedby, Karin E.; Sundström, Christer et al.

Part of Rheumatology, p. 809-819, 2021

• DOI for Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs: a Swedish cohort study of risks by time, drug and lymphoma subtype

Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Sundström, Christer; Hollander, Peter

Part of Immunobiology, 2021

• DOI for Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies
• Download full text (pdf) of Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Stratmann, Svea; Yones, Sara A.; Mayrhofer, Markus; Norgren, Nina et al.

Part of Blood Advances, p. 900-912, 2021

• DOI for Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Kinch, Amelie; Baecklund, Eva; Molin, Daniel; Pauksen, Karlis et al.

Part of Acta Oncologica, p. 771-778, 2021

• DOI for Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
• Download full text (pdf) of Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Abdulla, Maysaa; Alexsson, Andrei; Sundström, Christer; Ladenvall, Claes et al.

Part of Acta Oncologica, p. 531-538, 2021

• DOI for PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
• Download full text (pdf) of PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Population-based study of patients with primary Sjögren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences

Vasaitis, Lilian; Nordmark, Gunnel; Theander, E; Backlin, Carin et al.

Part of Scandinavian Journal of Rheumatology, p. 225-232, 2020

• DOI for Population-based study of patients with primary Sjögren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences

Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma

Thurner, Lorenz; Hartmann, Sylvia; Fadle, Natalie; Regitz, Evi et al.

Part of Nature Communications, 2020

• DOI for Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma
• Download full text (pdf) of Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma

CD30 expression and survival in posttransplant lymphoproliferative disorders

Kinch, Amelie; Amini, Rose-Marie; Hollander, Peter; Molin, Daniel et al.

Part of Acta Oncologica, p. 673-680, 2020

• DOI for CD30 expression and survival in posttransplant lymphoproliferative disorders
• Download full text (pdf) of CD30 expression and survival in posttransplant lymphoproliferative disorders

p53 is associated with high-risk and pinpointsTP53missense mutations in mantle cell lymphoma

Rodrigues, Joana M.; Hassan, May; Freiburghaus, Catja; Eskelund, Christian W. et al.

Part of British Journal of Haematology, p. 796-805, 2020

• DOI for p53 is associated with high-risk and pinpointsTP53missense mutations in mantle cell lymphoma
• Download full text (pdf) of p53 is associated with high-risk and pinpointsTP53missense mutations in mantle cell lymphoma

Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy

Menter, Thomas; Tzankov, Alexandar; Zucca, Emanuele; Kimby, Eva et al.

Part of British Journal of Haematology, p. 707-717, 2020

• DOI for Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Hellbacher, Erik; Hjorton, Karin; Backlin, Carin; Enblad, Gunilla et al.

Part of Acta Oncologica, p. 1655-1659, 2019

• DOI for Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome

Vasaitis, Lilian; Nordmark, Gunnel; Theander, E; Backlin, Carin et al.

Part of Scandinavian Journal of Rheumatology, p. 207-212, 2019

• DOI for Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome
• Download full text (pdf) of Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Gholiha, Alex R.; Hollander, Peter; Hedström, Gustaf; Sundström, Christer et al.

Part of British Journal of Haematology, p. 192-201, 2019

• DOI for High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Kinch, Amelie; Sundström, Christer; Baecklund, Eva; Backlin, Carin et al.

Part of Leukemia and Lymphoma, p. 376-384, 2019

• DOI for Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
• Download full text (pdf) of Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; Alafuzoff, Irina et al.

Part of Acta Oncologica, p. 187-194, 2018

• DOI for U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
• Download full text (pdf) of U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Malignant Lymphoma In Granulomatosis With Polyangiitis

Hellbacher, Erik; Hjorton, Karin; Sundström, Christer; Baecklund, Eva et al.

Part of Rheumatology, 2017

Rheumatoid Arthritis and Risk of Malignant Lymphoma - Is the risk still increased?

Hellgren, K.; Baecklund, Eva; Backlin, Carin; Sundström, Christer et al.

Part of Arthritis & Rheumatology, p. 700-708, 2017

• DOI for Rheumatoid Arthritis and Risk of Malignant Lymphoma - Is the risk still increased?

Nålbiopsi är inte bästa metod för att diagnostisera lymfom: [Core needle biopsies for lymphoma diagnosis seriously affect diagnostics, treatment development and research]

Amini, Rose-Marie; Sundström, Christer

Part of Läkartidningen, 2017

Numerous Ontogenetic Roads to Mantle Cell Lymphoma: Immunogenetic and Immunohistochemical Evidence

Pouliou, Evi; Xochelli, Aliki; Kanellis, George; Stalika, Evangelia et al.

Part of American Journal of Pathology, p. 1454-1458, 2017

• DOI for Numerous Ontogenetic Roads to Mantle Cell Lymphoma: Immunogenetic and Immunohistochemical Evidence

The role of Moraxella in the pathogenesis of IgD(+) nodular lymphocyte predominant Hodgkin lymphoma

Thurner, L.; Hartmann, S.; Kemele, M.; Fadle, N. et al.

Part of Oncology Research and Treatment, p. 143-143, 2017

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

Kolstad, Arne; Pedersen, Lone Bredo; Eskelund, Christian W.; Husby, Simon et al.

Part of Biology of blood and marrow transplantation, p. 428-435, 2017

• DOI for Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

Enblad, Gunilla; Martinsson, Gustaf; Baecklund, Eva; Hesselager, Göran et al.

Part of Acta Oncologica, p. 599-607, 2017

• DOI for Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma

Schwartz, Friederike H.; Cai, Qian; Fellmann, Eva; Hartmann, Sylvia et al.

Part of Journal of Pathology, p. 129-133, 2017

• DOI for TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma

Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma

Delforoush, Maryam; Berglund, Mattias; Edqvist, Per-Henrik; Sundström, Christer et al.

Part of European Journal of Haematology, p. 52-56, 2017

• DOI for Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma

Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren's syndrome diagnosis.

Vasaitis, Lilian; Sundström, Christer; Backlin, Carin; Nordmark, Gunnel et al.

Part of Acta Oncologica, p. 1139-1144, 2016

• DOI for Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren's syndrome diagnosis.

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.

Jardin, Fabrice; Pujals, Anais; Pelletier, Laura; Bohers, Elodie et al.

Part of American Journal of Hematology, p. 923-30, 2016

• DOI for Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.
• Download full text (pdf) of Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

Georgiou, Konstantinos; Chen, Longyun; Berglund, Mattias; Ren, Weicheng et al.

Part of Blood, p. 3026-3034, 2016

• DOI for Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau

Eskelund, Christian W.; Kolstad, Arne; Jerkeman, Mats; Raty, Riikka et al.

Part of British Journal of Haematology, p. 410-418, 2016

• DOI for 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Albertsson-Lindblad, Alexandra; Kolstad, Arne; Laurell, Anna; Raty, Riikka et al.

Part of Blood, p. 1814-1820, 2016

• DOI for Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder

Kinch, Amelie; Sundström, Christer; Tufveson, Gunnar; Glimelius, Ingrid

Part of Leukemia and Lymphoma, p. 2351-2358, 2016

• DOI for Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder

Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease

Brauner, S.; Zhou, W.; Backlin, Carin; Green, T. M. et al.

Part of Journal of Internal Medicine, p. 323-332, 2015

• DOI for Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease

Alterations of the CD58 gene in classical Hodgkin lymphoma

Schneider, Markus; Schneider, Stefanie; Zuehlke-Jenisch, Reina; Klapper, Wolfram et al.

Part of Genes, Chromosomes and Cancer, p. 638-645, 2015

• DOI for Alterations of the CD58 gene in classical Hodgkin lymphoma

Molecular Evidence for Antigen Drive in the Natural History of Mantle Cell Lymphoma

Xochelli, Aliki; Sutton, Lesley-Ann; Agathangelidis, Andreas; Stalika, Evangelia et al.

Part of American Journal of Pathology, p. 1740-1748, 2015

• DOI for Molecular Evidence for Antigen Drive in the Natural History of Mantle Cell Lymphoma

Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Knight, Ann; Hjorton, Karin; Sundström, Christer; Höglund, Martin et al.

Part of Journal of Rheumatology, p. 690-694, 2015

• DOI for Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Berglund, David; Kinch, Amelie; Edman, Elin; Backlin, Carin et al.

Part of Transplantation, p. 1036-1042, 2015

• DOI for Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

Husby, Simon; Ralfkiaer, Ulrik; Garde, Christian; Zandi, Roza et al.

Part of Blood, p. 2669-2677, 2015

• DOI for miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas

Kimby, Eva; Östenstad, Björn; Brown, Peter; Hagberg, Hans et al.

Part of Leukemia and Lymphoma, p. 2598-2607, 2015

• DOI for Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas

Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma: A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden

Hellgren, K.; Smedby, K. E.; Backlin, Carin; Sundström, Christer et al.

Part of Arthritis & Rheumatology, p. 1282-1290, 2014

• DOI for Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma: A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden

The Transcriptomic and Proteomic Landscapes of Bone Marrow and Secondary Lymphoid Tissues

Andersson, Sandra; Nilsson, Kenneth; Fagerberg, Linn; Hallstrom, Bjorn M. et al.

Part of PLOS ONE, 2014

• DOI for The Transcriptomic and Proteomic Landscapes of Bone Marrow and Secondary Lymphoid Tissues
• Download full text (pdf) of The Transcriptomic and Proteomic Landscapes of Bone Marrow and Secondary Lymphoid Tissues

Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Kinch, Amelie; Cavelier, Lucia; Bengtsson, Mats; Baecklund, Eva et al.

Part of American Journal of Transplantation, p. 2838-2845, 2014

• DOI for Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade

Libard, Sylwia; Popova, Svetlana N; Amini, Rose-Marie; Kärjä, Vesa et al.

Part of PLOS ONE, 2014

• DOI for Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade
• Download full text (pdf) of Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade

Ro52/TRIM21 Expression is Decreased in Malignant B Cells

Ivanchenko, Margarita; Brauner, Susanna; Enblad, Gunilla; Sundström, Christer et al.

Part of Scandinavian Journal of Immunology, p. 453-454, 2014

Nordic MCL-3 study: ⁹⁰Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

Kolstad, Arne; Laurell, Anna; Jerkeman, Mats; Grønbæk, Kirsten et al.

Part of Blood, p. 2953-2959, 2014

• DOI for Nordic MCL-3 study: ⁹⁰Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy

Wahlin, Bjorn Engelbrekt; Sundström, Christer; Sander, Birgitta; Christensson, Birger et al.

Part of Leukemia and Lymphoma, p. 288-295, 2014

• DOI for Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma: a Nordic Lymphoma Group study

Nordström, Lena; Sernbo, Sandra; Eden, Patrik; Grønbaek, Kirsten et al.

Part of British Journal of Haematology, p. 98-108, 2014

• DOI for SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma: a Nordic Lymphoma Group study

450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.

Cahill, Nicola; Bergh, A-C; Kanduri, M; Göransson-Kultima, H et al.

Part of Leukemia, p. 150-158, 2013

• DOI for 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.

Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

Brauner, Susanna; Zhou, Wei; Backlin, Carin; Green, Tina M. et al.

Part of Annals of the Rheumatic Diseases, 2013

• DOI for Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

DNA repair genes are selectively mutated in diffuse large B cell lymphomas

de Miranda, Noel F. C. C.; Peng, Roujun; Georgiou, Konstantinos; Wu, Chenglin et al.

Part of Journal of Experimental Medicine, p. 1729-1742, 2013

• DOI for DNA repair genes are selectively mutated in diffuse large B cell lymphomas

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

Holte, H.; Leppa, S.; Bjorkholm, M.; Fluge, O. et al.

Part of Annals of Oncology, p. 1385-1392, 2013

• DOI for Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

Does Biological Therapy Alter the Lymphoma Risk or Distribution of Lymphoma Subtypes in Patients with ra?

Baecklund, Eva; Hellgren, K.; Sundström, Christer; Askling, J.

Part of Annals of the Rheumatic Diseases, p. 427-427, 2013

• DOI for Does Biological Therapy Alter the Lymphoma Risk or Distribution of Lymphoma Subtypes in Patients with ra?

Entourage: the immune microenvironment following follicular lymphoma

Wahlin, B. E.; Sander, B.; Christensson, B.; Ostenstad, B. et al.

Part of Blood Cancer Journal, 2012

• DOI for Entourage: the immune microenvironment following follicular lymphoma

Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden

Fend, Falko; Cabecadas, José; Gaulard, Philippe; Jaffe, Elaine S et al.

Part of Journal of hematopathology, p. 169-199, 2012

• DOI for Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden

Rheumatoid Arthritis and Risks of Malignant Lymphoma: Are Risks Still Increased?

Hellgren, Karin; Baecklund, Eva; Smedby, Karin E.; Backlin, Carin et al.

Part of Arthritis and Rheumatism, 2012

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

d'Amore, Francesco; Relander, Thomas; Lauritzsen, Grete F.; Jantunen, Esa et al.

Part of Journal of Clinical Oncology, p. 3093-3099, 2012

• DOI for Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis

Du, Likun; Peng, Roujun; Björkman, Andrea; Filipe de Miranda, Noel et al.

Part of Journal of Experimental Medicine, p. 291-305, 2012

• DOI for Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis

Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times

Wahlin, Bjorn E.; Yri, Olav E.; Kimby, Eva; Holte, Harald et al.

Part of British Journal of Haematology, p. 225-233, 2012

• DOI for Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur

Geisler, Christian H.; Kolstad, Arne; Laurell, Anna; Jerkeman, Mats et al.

Part of British Journal of Haematology, p. 355-362, 2012

• DOI for Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur

MYC⁺ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

Cuccuini, Wendy; Briere, Josette; Mounier, Nicolas; Voelker, Hans-Ullrich et al.

Part of Blood, p. 4619-4624, 2012

• DOI for MYC⁺ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

Screening for Cytotoxic Compounds in Poor-prognostic Chronic Lymphocytic Leukemia

Norberg, Maria; Lindhagen, Elin; Kanduri, Meena; Rickardson, Linda et al.

Part of Anticancer Research, p. 3125-3136, 2012

Nordic MCL3 Study: Zevalin Combined with High-Dose Chemotherapy Followed by Autologous Stem Cell Support As Late Intensification for Mantle Cell Lymphoma (MCL) Patients < 66 Years Not in CR After Induction Chemoimmunotherapy: No Benefit of Zevalin

Arne, Kolstad; Laurell, Anna; Jerkeman, Mats; Gronbaek, Kirsten et al.

Part of Blood, p. 747, 2012

High Expression of Activation-Induced Cytidine Deaminase and in Vivo Class Switch Recombination in Mantle Cell Lymphoma: Further Support for Antigen Involvement in Lymphomagenesis

Xochelli, Aliki; Marantidou, Fotini; Stalika, Evangelia; Sutton, Lesley-Ann et al.

Part of Blood, p. 1538, 2012

Rituximab (R) in Combination with Interferon-a2a (IFN) Versus Single R in Patients with Follicular or Other CD20+Low-Grade (indolent) Lymphoma: Final Results From a Randomized Phase III Study From the Nordic Lymphoma Group

Kimby, Eva; Ostenstad, Bjorn; Brown, Peter de Nully; Holte, Harald et al.

Part of Blood, p. 794, 2012

Quantitative evaluation of p16^INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma

Zainuddin, Norafiza; Kanduri, Meena; Berglund, Mattias; Lindell, Monica et al.

Part of Leukemia Research, p. 438-443, 2011

• DOI for Quantitative evaluation of p16^INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma

In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia

Lönnerholm, Gudmar; Thörn, Ingrid; Sundström, Christer; Frost, Britt-Marie et al.

Part of Leukemia Research, p. 472-478, 2011

• DOI for In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia

Both CD4(+) FoxP3(+) and CD4(+) FoxP3(-) T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Lindqvist, Camilla; Christiansson, Lisa; Thörn, Ingrid; Mangsbo, Sara et al.

Part of Immunology, p. 296-306, 2011

• DOI for Both CD4(+) FoxP3(+) and CD4(+) FoxP3(-) T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.

Thörn, Ingrid; Forestier, Erik; Botling, Johan; Thuresson, Britt et al.

Part of British Journal of Haematology, p. 743-753, 2011

• DOI for Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.

T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab

Wahlin, Björn Engelbrekt; Sundström, Christer; Holte, Harald; Hagberg, Hans et al.

Part of Clinical Cancer Research, p. 4136-4144, 2011

• DOI for T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab

Impact of TP53 mutation and 17p deletion in mantle cell lymphoma

Halldórsdóttir, Anna Margret; Lundin, A; Murray, Fiona; Mansouri, Larry et al.

Part of Leukemia, 2011

• DOI for Impact of TP53 mutation and 17p deletion in mantle cell lymphoma

The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study

Thieblemont, Catherine; Briere, Josette; Mounier, Nicolas; Voelker, Hans-Ullrich et al.

Part of Journal of Clinical Oncology, p. 4079-4087, 2011

• DOI for The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study

hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup

Borssen, Magnus; Cullman, Inger; Noren-Nystrom, Ulrika; Sundström, Christer et al.

Part of Experimental Hematology, p. 1144-1151, 2011

• DOI for hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

Geisler, Christian H.; Kolstad, Arne; Laurell, Anna; Räty, Riikka et al.

Part of Blood, p. 1530-1533, 2010

• DOI for The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples

Andreasson, Ulrika; Edén, Patrik; Peterson, Carsten; Högerkorp, Carl-Magnus et al.

Part of American Journal of Hematology, p. 418-425, 2010

• DOI for Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples

Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006

Thörn, Ingrid; Forestier, Erik; Thuresson, Britt; Wasslavik, Carina et al.

Part of European Journal of Haematology, p. 117-127, 2010

• DOI for Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006

IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia

Mansouri, Mahmoud R; Sevov, Marie; Åleskog, Anna; Jondal, Mikael et al.

Part of European Journal of Haematology, p. 109-116, 2010

• DOI for IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia

In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia

Lönnerholm, Gudmar; Thörn, Ingrid; Sundström, Christer; Frost, Britt-Marie et al.

Part of Leukemia Research, p. 46-53, 2009

• DOI for In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia

In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukaemia: rolipram and prednisolone active in cells from patients with poor prognosis

Lindhagen, Elin; Norberg, Maria; Kanduri, Meena; Tobin, Gerard et al.

Part of European Journal of Haematology, p. 22-34, 2009

• DOI for In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukaemia: rolipram and prednisolone active in cells from patients with poor prognosis

Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells

Andréasson, Ulrika; Dictor, Michael; Jerkeman, Mats; Berglund, Mattias et al.

Part of American Journal of Hematology, p. 803-808, 2009

• DOI for Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells

A follicular dendritic cell line promotes somatic hypermutations in Ramos cells in vitro

Canedo, P.; Thorsélius, M.; Thunberg, Ulf; Sällström, J. et al.

Part of Scandinavian Journal of Immunology, p. 70-71, 2009

• DOI for A follicular dendritic cell line promotes somatic hypermutations in Ramos cells in vitro

Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma

Eckerle, S.; Brune, V.; Döring, C.; Tiacci, E. et al.

Part of Leukemia, p. 2129-2138, 2009

• DOI for Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma

Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome

Norén-Nyström, Ulrika; Heyman, Mats; Frisk, Per; Golovleva, Irina et al.

Part of British Journal of Haematology, p. 521-530, 2009

• DOI for Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome

Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers

Löfström, Björn; Backlin, Carin; Sundström, Christer; Hellström-Lindberg, Eva et al.

Part of Rheumatology, p. 1222-1226, 2009

• DOI for Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers

Genome-wide microarray-based comparative genomic hybridization analysis of lymphoplasmacytic lymphomas reveals heterogeneous aberrations

Buckley, Patrick G.; Walsh, Sarah H.; Laurell, Anna; Sundström, Christer et al.

Part of Leukemia and Lymphoma, p. 1528-34, 2009

• DOI for Genome-wide microarray-based comparative genomic hybridization analysis of lymphoplasmacytic lymphomas reveals heterogeneous aberrations

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Geisler, Christian H.; Kolstad, Arne; Laurell, Anna; Andersen, Niels S. et al.

Part of Blood, p. 2687-93, 2008

• DOI for Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Hepatitis C infection and risk of malignant lymphoma

Schöllkopf, Claudia; Smedby, Karin Ekström; Hjalgrim, Henrik; Rostgaard, Klaus et al.

Part of International Journal of Cancer, p. 1885-1890, 2008

• DOI for Hepatitis C infection and risk of malignant lymphoma

The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia

Kaderi, Mohd Arifin; Norberg, Maria; Murray, Fiona; Merup, M. et al.

Part of Leukemia, p. 339-343, 2008

• DOI for The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia

Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group

Kimby, Eva; Jurlander, Jesper; Geisler, Christian; Hagberg, Hans et al.

Part of Leukemia and Lymphoma, p. 102-112, 2008

• DOI for Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

Baecklund, Eva; Natkunam, Yasodha; Backlin, Carin; Iliadou, Anastasia et al.

Part of British Journal of Haematology, p. 69-72, 2008

• DOI for Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner

Boström, Hans; Leuchowius, Karl-Johan; Hallböök, Helene; Nordgren, Ann et al.

Part of European Journal of Haematology, p. 218-225, 2008

• DOI for U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner

Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas

Schain, Frida; Schain, Daniel; Mahshid, Yilmaz; Liu, Cheng et al.

Part of Clinical lymphoma & myeloma, p. 340-7, 2008

• DOI for Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas

Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

Hedström, Gustaf; Berglund, Mattias; Molin, Daniel; Fischer, Marie et al.

Part of British Journal of Haematology, p. 68-71, 2007

• DOI for Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas

Walsh, Sarah H.; Grabowski, Pawel; Berglund, Mattias; Thunberg, Ulf et al.

Part of European Journal of Haematology, p. 283-289, 2007

• DOI for Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas

Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma

Berglund, Mattias; Enblad, Gunilla; Thunberg, Ulf; Amini, Rose-Marie et al.

Part of Modern Pathology, p. 63-75, 2007

• DOI for Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma

Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma

Hjalgrim, Henrik; Smedby, Karin Ekström; Rostgaard, Klaus; Molin, Daniel et al.

Part of Cancer Research, p. 2382-2388, 2007

• DOI for Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma

A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study

Löfström, B.; Backlin, Carin; Sundström, Christer; Ekbom, A. et al.

Part of Annals of the Rheumatic Diseases, p. 1627-1632, 2007

• DOI for A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study

Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro

Bäckman, Eva; Bergh, Ann-Charlotte; Lagerdahl, Irena; Rydberg, Björn et al.

Part of Haematologia, p. 1495-1504, 2007

• DOI for Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro

Atopy and risk of non-Hodgkin lymphoma

Melbye, Mads; Smedby, Karin Ekström; Lehtinen, Tuula; Rostgaard, Klaus et al.

Part of Journal of the National Cancer Institute, p. 158-166, 2007

• DOI for Atopy and risk of non-Hodgkin lymphoma

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

Baecklund, Eva; Iliadou, Anastasia; Askling, Johan; Ekbom, Anders et al.

Part of Arthritis and Rheumatism, p. 692-701, 2006

• DOI for Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

IL-9 expression contributes to the cellular composition in Hodgkin lymphoma

Glimelius, Ingrid; Edström, Annika; Amini, Rose-Marie; Fischer, Marie et al.

Part of European Journal of Haematology, p. 278-283, 2006

• DOI for IL-9 expression contributes to the cellular composition in Hodgkin lymphoma

Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis

Baecklund, Eva; Backlin, Carin; Iliadou, Anastasia; Granath, Fredrik et al.

Part of Arthritis and Rheumatism, p. 3774-3781, 2006

• DOI for Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype

Smedby, Karin Ekström; Hjalgrim, Henrik; Askling, Johan; Chang, Ellen T. et al.

Part of Journal of the National Cancer Institute, p. 51-60, 2006

• DOI for Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype

The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia.

Skogsberg, S; Tobin, G; Kröber, A; Kienle, D et al.

Part of Leukemia, p. 77-81, 2006

Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14).

Adde, Magdalena; Enblad, Gunilla; Hagberg, Hans; Sundström, Christer et al.

Part of Med Oncol, p. 283-93, 2006

U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.

Sambade, Clara; Berglund, Mattias; Lagercrantz, Svetlana; Sällström, Jan et al.

Part of Int J Cancer, p. 555-63, 2006

Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia

Thorsélius, Mia; Walsh, Sarah H.; Thunberg, Ulf; Hagberg, Hans et al.

Part of Leukemia Research, p. 153-158, 2005

• DOI for Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia

In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia

Hallböök, Helene; Barbany, Gisela; Åleskog, Anna; Björnberg, Annelie et al.

Part of Anti-Cancer Drugs, p. 631-634, 2005

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Askling, J; Fored, C M; Baecklund, Eva; Brandt, L et al.

Part of Annals of the Rheumatic Diseases, p. 1414-1420, 2005

• DOI for Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Angiogenesis and mast cells in Hodgkin lymphoma

Glimelius, Ingrid; Edström, Annika; Fischer, Marie; Nilsson, Gunnar et al.

Part of Leukemia, p. 2360-2362, 2005

• DOI for Angiogenesis and mast cells in Hodgkin lymphoma

Ultraviolet radiation exposure and risk of malignant lymphomas

Smedby, Karin Ekström; Hjalgrim, Henrik; Melbye, Mads; Torrång, Anna et al.

Part of Journal of the National Cancer Institute, p. 199-209, 2005

• DOI for Ultraviolet radiation exposure and risk of malignant lymphomas

Medication use and risk of non-Hodgkin's lymphoma

Chang, Ellen T.; Smedby, Karin Ekström; Hjalgrim, Henrik; Schöllkopf, Claudia et al.

Part of American Journal of Epidemiology, p. 965-974, 2005

• DOI for Medication use and risk of non-Hodgkin's lymphoma

Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or V(H) gene mutation status in chronic lymphocytic leukaemia.

Tobin, Gerard; Skogsberg, Åsa; Thunberg, Ulf; Laurell, Anna et al.

Part of Leukemia, p. 871-873, 2005

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.

Berglund, Mattias; Thunberg, Ulf; Amini, Rose-Marie; Book, Majlis et al.

Part of Mod Pathol, p. 1113-20, 2005

Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.

Tobin, Gerard; Thunberg, Ulf; Laurell, Anna; Karlsson, Karin et al.

Part of Haematologica, p. 465-9, 2005

Use of cellular or cordless telephones and the risk for non-Hodgkin's lymphoma.

Hardell, Lennart; Eriksson, Mikael; Carlberg, Michael; Sundstrom, Christer et al.

Part of Int Arch Occup Environ Health, p. 625-32, 2005

Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.

Vilpo, Juhani; Tobin, Gerard; Hulkkonen, Janne; Hurme, Mikko et al.

Part of Eur J Haematol, p. 34-40, 2005

[Limit investigation in cancer of unknown primary site]

Berglund, Ake; Nygren, Peter; Hagberg, Hans; Pahlman, Lars et al.

Part of Lakartidningen, p. 2946-8, 2950, 2005

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.

Grabowski, Pawel; Hultdin, Magnus; Karlsson, Karin; Tobin, Gerard et al.

Part of Blood, p. 4807-12, 2005

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.

Tobin, Gerard; Thunberg, Ulf; Karlsson, Karin; Murray, Fiona et al.

Part of Blood, p. 2879-85, 2004

Similar humoral immunity parameters in chronic lymphocytic leukemia patients independent of VH gene mutation status.

Sinisalo, Marjatta; Aittoniemi, Janne; Koski, Tomi; Tobin, Gerard et al.

Part of Leuk Lymphoma, p. 2451-4, 2004

VH gene mutation status and cellular drug resistance in chronic lymphocytic leukemia

Åleskog, Anna; Tobin, Gerard; Laurell, Anna; Thunberg, Ulf et al.

Part of Eur J Haematol, p. 407-411, 2004

Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue.

Fischer, Marie; Juremalm, Mikael; Olsson, Niclas; Backlin, Carin et al.

Part of Int J Cancer, p. 197-201, 2003

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

Tobin, Gerard; Thunberg, Ulf; Johnson, Anna; Eriksson, Inger et al.

Part of Blood, p. 4952-7, 2003

Ex vivo drug and irradiation sensitivities in hypermutated and unmutatedforms of chronic lymphocytic leukemia cells.

Kivekas, I; Tobin, G; Thunberg, U; Vilpo, L et al.

Part of Leuk Res, p. 337, 2003

Association between telomere length and V(H) gene mutation status inchronic lymphocytic leukaemia: clinical and biological implications.

Hultdin, M; Rosenquist, R; Thunberg, U; Tobin, G et al.

Part of Br J Cancer, p. 593, 2003

Analysis of a clonally related mantle cell and Hodgkin lymphoma indicatesEpstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor ina germinal center.

Tinguely, M; Rosenquist, R; Sundstrom, C; Amini, RM et al.

Part of Am J Surg Pathol, p. 1483, 2003

Increased serum levels of Interleukin-9 correlates with negative prognostic factors in Hodgkin's lymphoma

Fischer, Marie; Molin, Daniel; Bijman, Marcel; Cormont, Francoise et al.

Part of Leukemia, p. 2513, 2003

Surface antigen expression and correlation with variable heavy-chain genemutation status in chronic lymphocytic leukemia.

Vilpo, J; Tobin, G; Hulkkonen, J; Hurme, M et al.

Part of Eur J Haematol, p. 53, 2003

More extensive genetic alterations in unmutated than in hypermutated casesof chronic lymphocytic leukemia.

Karhu, R; Tobin, G; Thunberg, U; Vilpo, L et al.

Part of Genes Chromosomes Cancer, p. 417, 2003

A novel B-cell line (U-2932) established from a patient with a diffuse large B-cell lymphoma following Hodgkin lymphoma

Amini, Rose-Marie; Berglund, Mattias; Rosenquist, Richard; von Heideman, Anne et al.

Part of Leukemia and Lymphoma, p. 2179-2189, 2002

• DOI for A novel B-cell line (U-2932) established from a patient with a diffuse large B-cell lymphoma following Hodgkin lymphoma

Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival

Amini, Rose-Marie; Enblad, Gunilla; Engström, Peter; Christensson, Birger et al.

Part of Leukemia and Lymphoma, p. 1253-1260, 2002

• DOI for Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival

Response to "Do B-cell chronic lymphocytic leukemia patients with Ig VH3-21 genes constitute a new subset of chronic lymphocytic leukemia?": IgV_H3-21 gene usage in chronic lymphocytic leukemia

Tobin, Gerard; Thunberg, Ulf; Johnson, Anna; Söderberg, Ola et al.

Part of Blood, p. 1098-1099, 2002

• DOI for Response to "Do B-cell chronic lymphocytic leukemia patients with Ig VH3-21 genes constitute a new subset of chronic lymphocytic leukemia?": IgV_H3-21 gene usage in chronic lymphocytic leukemia

Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia

Thunberg, Ulf; Tobin, Gerard; Johnson, Anna; Söderberg, Ola et al.

Part of The Lancet, p. 1935-1939, 2002

• DOI for Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

Tobin, Gerard; Thunberg, Ulf; Johnson, Anna; Thörn, Ingrid et al.

Part of Blood, p. 2262-2264, 2002

Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients

Amini, Rose-Marie; Enblad, Gunilla; Sundström, Christer; Glimelius, Bengt

Part of International Journal of Cancer, p. 510-516, 1997

• DOI for Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients

Characterization of a human basophil-like cell line (LAMA-84)

Blom, T; Nilsson, G; Sundström, C; Nilsson, K et al.

Part of Scand. J. Immunol., p. 54-61, 1996

SUPPLEMENTARY MATERIAL: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2021

SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2020

• Download full text (pdf) of SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression